12 results on '"Disgenesia gonadal"'
Search Results
2. Disgenesia gonadal completa 46,XY o síndrome de Swyer: reporte de un caso.
- Author
-
Añorve-Vargas, Alexis, Pérez-López, José del Carmen, MandujanoÁlvarez, Gabriel Juan, Domínguez-Morales, Ever, and Contreras-Albavera, Elfego Octavio
- Subjects
GONADAL dysgenesis ,AMENORRHEA ,PHENOTYPES ,GENOTYPES ,KARYOTYPES ,HYPOGONADISM ,FETAL development - Abstract
Copyright of Ginecología y Obstetricia de México is the property of Federacion Mexicana de Ginecologia y Obstetricia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2022
- Full Text
- View/download PDF
3. Nueva variante del gen STAG3 causante de insuficiencia ovárica prematura
- Author
-
Susana Gómez-Rojas, Jorge Enrique Aristizábal-Duque, Luisa Fernanda Muñoz-Fernández, María Paula Sarmiento-Ramón, and María del Pilar Pereira-Gómez
- Subjects
hipogonadismo ,insuficiencia ovárica primaria ,disgenesia gonadal ,autoinmunidad ,secuenciación del exoma completo ,Gynecology and obstetrics ,RG1-991 - Abstract
Objetivos: describir un caso de falla ovárica secundaria a una variante patogénica homocigota en el gen STAG3 no reportada previamente. Materiales y métodos: paciente de 16 años con amenorrea primaria y ausencia de características sexuales secundarias, en quien se documentó hipotiroidismo autoinmune, pobre desarrollo genital y cintilla gonadal, por lo cual se realizó secuenciación de exoma clínico. Se identificó una variante homocigota patogénica previamente no reportada en el gen STAG3, el cual ha sido relacionado con insuficiencia ovárica prematura (IOP). Conclusiones: en este caso, la realización de exoma clínico fue determinante para identificar una alteración del gen STAG, probablemente asociada a la IOP y el pronóstico a largo plazo de la paciente. Se establece una nueva variante patogénica c.2773delT; p.Ser925Profs*6 del gen STAG3 asociada a la IOP. Palabras claves: hipogonadismo, insuficiencia ovárica primaria, disgenesia gonadal, autoinmunidad, secuenciación del exoma completo.
- Published
- 2022
- Full Text
- View/download PDF
4. Nueva variante del gen STAG3 causante de insuficiencia ovárica prematura.
- Author
-
Gómez-Rojas, Susana, Enrique Aristizábal-Duque, Jorge, Fernanda Muñoz-Fernández, Luisa, Paula Sarmiento-Ramón, María, and Pilar Pereira-Gómez, María del
- Subjects
- *
PREMATURE ovarian failure , *GENETIC variation , *GONADAL dysgenesis , *AMENORRHEA , *HYPOTHYROIDISM , *PREMATURE menopause ,GONADAL diseases - Abstract
Objectives: To describe a case of ovarian failure secondary to a homozygous pathogenic variant in the STAG3 gene not previously reported. Material and methods: A 16-year-old patient with primary amenorrhea and absence of secondary sexual characteristics, with documented autoimmune hypothyroidism, poor genital and gonadal streak development which prompted the performance of clinical exome sequencing. A homozygous pathogenic variant not previously reported in the STAG3 gene, which has been associated with premature ovarian insufficiency (POI), was identified. Conclusions: In this case, clinical exome sequencing was key for identifying a STAG gene abnormality, probably associated with POI and long term prognosis for the patient. A new pathogenic variant c.2773delT; p.Ser925Profs*6 of the STAG3 gene associated with POI was established. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
5. Biomarcadores de hipogonadismo masculino en la infancia y la adolescencia
- Author
-
Rey Rodolfo A.
- Subjects
ambigüedad genital ,criptorquidia ,disgenesia gonadal ,hipogonadismo hipergonadotrófico ,hipogonadismo hipogonadotrófico ,micropene ,testículo ,trastornos del desarrollo sexual ,Medical technology ,R855-855.5 - Abstract
El eje hipotálamo-hipófiso-testicular es activo en la vida fetal y durante los primeros meses de la vida posnatal: la hipófisis secreta hormona luteinizante (LH) y folículo-estimulante (FSH), mientras que el testículo produce testosterona y factor insulino-símil 3 (INSL3) en las células de Leydig y hormona anti-Mülleriana (AMH) e inhibina B en las células de Sertoli. En la infancia, los niveles séricos de gonadotrofinas, testosterona y factor INSL3 disminuyen a valores prácticamente indetectables, pero los de AMH e inhibina B permanecen altos. En la pubertad, se reactivan las gonadotrofinas y la producción de testosterona e INSL3, aumenta la inhibina y disminuye la AMH, como signo de maduración de la célula de Sertoli. Sobre la base del conocimiento de la fisiología del desarrollo del eje, es posible utilizar clínicamente estos biomarcadores para interpretar la fisiopatología y diagnosticar las diferentes formas de hipogonadismo que pueden presentarse en la infancia y la adolescencia.
- Published
- 2020
- Full Text
- View/download PDF
6. Agenesia uterina y ovárica. Una combinación inusual causante de hipogonadismo hipergonadotropo (HH).
- Author
-
Benítez Cardoza, María Clara and García Bermejo, Roberto
- Abstract
Introduction: hypergonadotropic Hypogonadism (HH) is the cause of delayed puberty, characterized by an intrinsic gonadal condition that interrupts the action of the hypothalamic-pituitary-gonadal axis. With a varied etiology, including genetic or acquired alterations. The association of uterine and ovarian agenesis in the same patient as the cause of HH is unusual. There are cases described in the HH literature with agenesis, dysgenesis, ovarian hypoplasia, but without uterine alteration. Case description: 12-year-old patient who consults for short stature with absence of pubertal development. Hormonal studies suffering from HH. Pelvic ultrasound and pelvic magnetic resonance imaging are requested, confirming gonadal and uterine agenesis. Management is performed with calcium supplements, estrogens as hormonal replacement to induce secondary sexual characteristics and support in your bone health. Achieve a normal final size according to your average parental size and improvement in your quality of life. Discussion: short stature and absence of secondary sexual characteristics is a form of clinical presentation of HH. Ovarian agenesis as a cause of HH, associated with uterine agenesis in the same patient, is an unusual association, motivating the publication of the case. Conclusion: it is important to recognize HH early, in order to provide timely treatment, and thus improve quality of life. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
7. Abordaje del recién nacido con alteraciones del desarrollo sexual.
- Author
-
Acosta-Rodríguez, Ariana Liseth and Mendoza-Rojas, Víctor Clemente
- Published
- 2019
- Full Text
- View/download PDF
8. Síndrome de Frasier en una adolescente: asociación con disgenesia gonadal y enfermedad renal crónica.
- Author
-
Fernández Rodríguez, Yaribel, Sardinas Solís, Rosa María, and Aguilera Yumbet, Yania
- Abstract
The case report of a 16 years adolescent with apparent good health state who had been attended approximately for 3 years in the Pediatrics service to present lack of puberal changes, primary amenorrhoea, as well as increase of volume in lower members is described. The pertinent and complementary examinations were carried out and taking into account the group of clinical elements she presented, including a significant proteinuria associated with corporal dysmorfisms and hypogenitalism, the case was exposed to a multidisciplinary team, formed by nephrologists, Endocrinology specialists, geneticists and psychologists. Frasier syndrome was diagnosed, associated to nephrotic syndrome and gonadal dysgenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2019
9. Prevalence of Y-chromosome sequences and gonadoblastoma in Turner syndrome
- Author
-
Alessandra Bernadete Trovó de Marqui, Roseane Lopes da Silva-Grecco, and Marly Aparecida Spadotto Balarin
- Subjects
Síndrome de Turner ,Cromossomo Y ,Gonadoblastoma ,Prevalência ,Reação em cadeia da polimerase ,Disgenesia gonadal ,Pediatrics ,RJ1-570 - Abstract
Abstract Objective: To assess the prevalence of Y-chromosome sequences and gonadoblastoma in patients with Turner syndrome (TS) using molecular techniques. Data source: A literature search was performed in Pubmed, limiting the period of time to the years 2005–2014 and using the descriptors: TS and Y sequences (n=26), and TS and Y-chromosome material (n=27). The inclusion criteria were: articles directly related to the subject and published in English or Portuguese. Articles which did not meet these criteria and review articles were excluded. After applying these criteria, 14 papers were left. Data synthesis: The main results regarding the prevalence of Y-chromosome sequences in TS were: (1) about 60% of the studies were conducted by Brazilian researchers; (2) the prevalence varied from 4.6 to 60%; (3) the most frequently investigated genes were SRY, DYZ3 and TSPY; (4) seven studies used only polymerase chain reaction, while in the remaining seven it was associated with FISH. Nine of the 14 studies reported gonadectomy and gonadoblastoma. The highest prevalence of gonadoblastoma (33%) was found in two studies. In five out of the nine papers evaluated the prevalence of gonadoblastoma was 10–25%; in two of them it was zero. Conclusions: According to these data, molecular analysis to detect Y-chromosome sequences in TS patients is indicated, regardless of their karyotype. In patients who test positive for these sequences, gonadoblastoma needs to be investigated.
- Published
- 2016
- Full Text
- View/download PDF
10. Variedades clínicas de la disgenesia gonadal
- Author
-
Jairo Bustamante B., Iván Molina V., Fernando Cardona A., Arturo Orrego, and Victoria E. Botero D.
- Subjects
disgenesia gonadal ,pterium colli ,ginecología ,pediatría ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
Fragmento En el presente estudio se hace una revisión de los aspectos clínicos y citológicos de 16 casos de disgenesia gonadal estudiados en los Departamentos de Medicina Interna, Ginecología y Pediatría del Hospital Universitario San Vicente de Paúl de Medellín en los años 1967 y 1968.
- Published
- 2018
- Full Text
- View/download PDF
11. Prevalence of Y-chromosome sequences and gonadoblastoma in Turner syndrome.
- Author
-
Trovó de Marqui, Alessandra Bernadete, da Silva-Grecco, Roseane Lopes, and Spadotto Balarin, Marly Aparecida
- Subjects
- *
Y chromosome , *TURNER'S syndrome , *GONADAL dysgenesis - Abstract
Objective: To assess the prevalence of Y-chromosome sequences and gonadoblastoma in patients with Turner syndrome (TS) using molecular techniques. Data source: A literature search was performed in Pubmed, limiting the period of time to the years 2005-2014 and using the descriptors: TS and Y sequences (n=26), and TS and Y- chromosome material (n=27). The inclusion criteria were: articles directly related to the subject and published in English or Portuguese. Articles which did not meet these criteria and review articles were excluded. After applying these criteria, 14 papers were left. Data synthesis: The main results regarding the prevalence of Y-chromosome sequences in TS were: (1) about 60% of the studies were conducted by Brazilian researchers; (2) the prevalence varied from 4.6 to 60%; (3) the most frequently investigated genes were SRY, DYZ3 and TSPY; (4) seven studies used only polymerase chain reaction, while in the remaining seven it was associated with FISH. Nine of the 14 studies reported gonadectomy and gonadoblastoma. The highest prevalence of gonadoblastoma (33%) was found in two studies. In five out of the nine papers evaluated the prevalence of gonadoblastoma was 10-25%; in two of them it was zero. Conclusions: According to these data, molecular analysis to detect Y-chromosome sequences in TS patients is indicated, regardless of their karyotype. In patients who test positive for these sequences, gonadoblastoma needs to be investigated. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
12. Estudo citogenético das gônadas em pacientes com amenorréia primária Gonadal cytogenetic analysis in patients with primary amenorrhea
- Author
-
Carla D'Agostini, Rejane Gus, Edison Capp, and Helena von Eye Corleta
- Subjects
Amenorréia ,Disgenesia gonadal ,Cariótipo ,Amenorrhea ,Gonadal dysgenesia ,Karyotype ,Gynecology and obstetrics ,RG1-991 - Abstract
INTRODUÇÃO: pacientes em amenorréia primária com disgenesia gonadal têm níveis elevados de gonadotrofinas e necessitam de avaliação cromossômica. O estudo citogenético (cariótipo) pode ser realizado na gônada ou no sangue periférico. Nos casos de amenorréia primária sem sinal de virilização, a necessidade de investigação adicional do cariótipo da gônada não está estabelecida. OBJETIVO: revisar os cariótipos de gônadas (ovários) de mulheres com amenorréia primária e compará-los com os resultados do cariótipo no sangue periférico, relacionando-os às características fenotípicas das pacientes. MÉTODOS: foram analisados retrospectivamente os dados clínicos e os cariótipos de doze pacientes atendidas no período de janeiro de 1997 a dezembro de 2003 no Hospital de Clínicas de Porto Alegre. RESULTADOS: nas pacientes incluídas, quando o motivo da investigação foi amenorréia primária sem sinal de virilização, o cariótipo da gônada foi concordante com o cariótipo do sangue periférico nos oito casos avaliados (sete pacientes com cariótipo 46XX e uma paciente com cariótipo 46XY). A paciente oito foi a única com sinal de virilização (hipertrofia de clitóris) e o único caso de cariótipos discordantes. CONCLUSÃO: este estudo sugere que o cariótipo de gônada não traz informação adicional ao cariótipo do sangue periférico nas pacientes com amenorréia primária sem sinais de virilização. Até o momento todos os trabalhos publicados tiveram número pequeno de pacientes. A análise da relação custo-benefício pode permitir redução de estresse psicológico para paciente e familiares, bem como redução de custos para as instituições.BACKGROUND: patients with primary amenorrhea and gonadal dysgenesia have higher serum gonadotrophins and should be submitted to chromosome studies. Karyotype studies may be performed in gonadal tissue or peripheral blood however, it is not yet established if cases of primary amenorrhea without signs of virilization need additional investigation of gonadal karyotype. PURPOSE: to analize the gonadal karyotypes (ovaries) from patients with primary amenorrhea and compare them to their respective peripheral blood karyotypes. METHODS: clinical and karyotype data of 12 patients were retrospectively analyzed from January 1997 to December 2003. RESULTS: when the investigation was indicated for primary amenorrhea without signs of virilization, the gonadal and peripheral blood karyotypes were concordant in 8 cases (7 cases 46XX and 1 case 46XY). One patient with virilization signs was the only case of discordant karyotype. CONCLUSION: the present study suggests that the gonadal karyotype does not bring additional information to peripheral blood karyotype in patients with amenorrhea and no signs of virilization. Although all previous studies had a small number of patients, it seems advisable to investigate the gonadal karyotype in patients with signs of virilization. The cost-benefit analysis could allow cost and stress reduction for patients, family and institutions.
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.